AAAAAA
Results: 1-25/136
Authors:
JAMERSON B
JORENBY D
DONAHUE R
JOHNSTON A
FIORE M
NIDES M
RENNARD S
LEISCHOW S
Citation: B. Jamerson et al., LATE-TERM SMOKING ABSTINENCE DESPITE INITIAL FAILURE - EVALUATION OF BUPRIOPION SUSTAINED-RELEASE, NICOTINE REPLACEMENT, AND COMBINATION, Journal of addictive diseases, 17(4), 1998, pp. 15-15
Authors:
LONGUETHIGGINS HC
KOENDERINK JJ
TRIGGS W
FITZGIBBON A
FOSTER D
JOHNSTON A
Citation: Hc. Longuethiggins et al., PICTORIAL RELIEF - DISCUSSION, Philosophical transactions-Royal Society of London. Physical sciences and engineering, 356(1740), 1998, pp. 1085-1086
Authors:
PIVOT X",KELLY,TORTOCHAUX,BELPOMME,HUMBLET,DOMENGE,"JOHNSTON A
CLINDENANN N
PENNING C
SCHNEIDER M
Citation: A. Pivot X",kelly,tortochaux,belpomme,humblet,domenge,"johnston et al., A PHASE-III TRIAL OF NOLATREXED VERSUS METHOTREXATE IN PATIENTS (PTS)WITH ADVANCED OR RECURRENT SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK (SCCHN), Annals of oncology, 9, 1998, pp. 358-358
Authors:
HUGHES AN
GRIFFIN MJ
CALVERT AH
JOHNSTON A
KERR B
LEE C
NEWELL DR
BODDY AV
Citation: An. Hughes et al., PHARMACOKINETIC INTERACTIONS IN A PHASE-I STUDY OF NOLATREXED (AG337,THYMITAQ(TM)) AND PACLITAXEL IN PATIENTS WITH ADVANCED SOLID TUMORS, Annals of oncology, 9, 1998, pp. 463-463
Authors:
TAYLOR GA
ESTLIN EJ
PINKERTON CR
GOWING R
LASHFORD L
MORLAND B
LEWIS IJ
NEWELL DR
BODDY AV
JOHNSTON A
PEARSON ADJ
Citation: Ga. Taylor et al., DEOXYURIDINE PLASMA-LEVELS DURING THE PHASE-I STUDY OF NOLATREXED IN CHILDREN WITH ADVANCED CANCER, Annals of oncology, 9, 1998, pp. 618-618
Authors:
MANI S
ROSEN L
BENNETT P
DANCEY J
CONNER S
JOHNSTON A
CLENDENINN N
Citation: S. Mani et al., A PHASE-II TRIAL OF NOLATREXED DIHYDROCHLORIDE [THYMITAQ, AG337] IN PATIENTS WITH ADVANCED HEPATOCELLULAR-CARCINOMA (HCC), Annals of oncology, 9, 1998, pp. 619-619
Authors:
MOK T
LIU M
LEE SD
CHAO Y
LEUNG T
JOHNSTON A
JOHNSON P
Citation: T. Mok et al., A PHASE II III RANDOMIZED STUDY COMPARING EFFICACY OF NOLATREXED (THYMITAQ, AG337) TO DOXORUBICIN IN PATIENTS WITH UNRESECTABLE HEPATOCELLULAR-CARCINOMA (HCC)/, Annals of oncology, 9, 1998, pp. 664-664
Authors:
JOHNSTON A
KING LA
Citation: A. Johnston et La. King, HEROIN PROFILING - PREDICTING THE COUNTRY-OF-ORIGIN OF SEIZED HEROIN, Forensic science international, 95(1), 1998, pp. 47-55
Authors:
CREAVEN PJ
PENDYALA L
MEROPOL NJ
CLENDENINN NJ
WU EY
LOEWEN GM
PROEFROCK A
JOHNSTON A
DIXON M
Citation: Pj. Creaven et al., INITIAL CLINICAL-TRIAL AND PHARMACOKINETICS OF THYMITAQ(TM) (AG337) BY 10-DAY CONTINUOUS-INFUSION IN PATIENTS WITH ADVANCED SOLID TUMORS, Cancer chemotherapy and pharmacology, 41(2), 1998, pp. 167-170
Authors:
JOHNSTON A
MCOWAN PW
Citation: A. Johnston et Pw. Mcowan, MODELING BIOLOGICAL MOTION ANALYSIS IN TERMS OF IMAGE FLOW, Perception, 27(2), 1998, pp. 4-4
Authors:
MARTIN P
HANCOCK GJ
JOHNSTON A
MURRAY AS
Citation: P. Martin et al., NATURAL-SERIES RADIONUCLIDES IN TRADITIONAL NORTH AUSTRALIAN ABORIGINAL FOODS, Journal of environmental radioactivity, 40(1), 1998, pp. 37-58
Authors:
MCKNIGHT GM
HORN S
OBYRNE S
JOHNSTON A
BENJAMIN N
Citation: Gm. Mcknight et al., PLATELET AGGREGATION-INHIBITION BY INGESTION OF DIETARY NITRATE, Hypertension, 32(4), 1998, pp. 402-402
Authors:
FORTE P
KNEALE BJ
MILNE E
CHOWIENCZYK PJ
JOHNSTON A
BENJAMIN N
RITTER JM
Citation: P. Forte et al., EVIDENCE FOR A DIFFERENCE IN NITRIC-OXIDE BIOSYNTHESIS BETWEEN HEALTHY WOMEN AND MEN, Hypertension, 32(4), 1998, pp. 730-734
Authors:
KEOWN P
KAHAN BD
JOHNSTON A
LEVY G
DUNN SP
CITTERO F
GRINO JM
HOYER PF
WOLF P
HALLORAN PF
Citation: P. Keown et al., OPTIMIZATION OF CYCLOSPORINE THERAPY WITH NEW THERAPEUTIC DRUG-MONITORING STRATEGIES - REPORT FROM THE RNATIONAL-NEORAL(R)-TDM-ADVISORY-CONSENSUS-MEETING (VANCOUVER, NOVEMBER 1997), Transplantation proceedings, 30(5), 1998, pp. 1645-1649
Authors:
JOHNSTON A
HOLT DW
Citation: A. Johnston et Dw. Holt, GENERIC SUBSTITUTION FOR CYCLOSPORINE - WHAT SHOULD WE BE LOOKING FORIN NEW FORMULATIONS, Transplantation proceedings, 30(5), 1998, pp. 1652-1653
Authors:
JOHNSTON A
Citation: A. Johnston, 'IN LONDON WITH YOU', Landfall, (195), 1998, pp. 65-65
Authors:
HOLT DW
JONES K
JOHNSTON A
HORWATT R
HICKS D
Citation: Dw. Holt et al., AN IMMUNOASSAY FOR THE MEASUREMENT OF SIROLIMUS, Clinical chemistry, 44, 1998, pp. 412-412
Authors:
BEARDALL J
JOHNSTON A
RAVEN J
Citation: J. Beardall et al., ENVIRONMENTAL-REGULATION OF CO2-CONCENTRATING MECHANISMS IN MICROALGAE, Canadian journal of botany, 76(6), 1998, pp. 1010-1017
Authors:
HOLT DW
JOHNSTON A
Citation: Dw. Holt et A. Johnston, CYCLOSPORINE MICROEMULSION - A GUIDE TO USAGE AND MONITORING, Biodrugs, 7(3), 1997, pp. 175-197
Authors:
KNIGHT B
JOHNSTON A
Citation: B. Knight et A. Johnston, THE ROLE OF MOVEMENT IN FACE RECOGNITION, Visual cognition, 4(3), 1997, pp. 265-273
Authors:
JOHNSTON A
MARTIN P
Citation: A. Johnston et P. Martin, RAPID ANALYSIS OF RA-226 IN WATERS BY GAMMA-RAY SPECTROMETRY, Applied radiation and isotopes, 48(5), 1997, pp. 631-638
Authors:
OBRIEN J
JOHNSTON A
Citation: J. Obrien et A. Johnston, WHEN TEXTURE IS A STRONGER DEPTH CUE THAN MOTION, Perception, 26(10), 1997, pp. 20-20
Authors:
THEBAUD C
JOHNSTON A
Citation: C. Thebaud et A. Johnston, PLANT-RESPONSES TO GLOBAL CHANGES IN CO2 - UNFINISHED BUSINESS, Trends in ecology & evolution, 12(11), 1997, pp. 425-426
Authors:
JOHNSTON A
KEOWN PA
HOLT DW
Citation: A. Johnston et al., SIMPLE BIOEQUIVALENCE CRITERIA - ARE THEY RELEVANT TO CRITICAL DOSE DRUGS - EXPERIENCE GAINED FROM CYCLOSPORINE, Therapeutic drug monitoring, 19(4), 1997, pp. 375-381
Authors:
HOLT DW
JOHNSTON A
Citation: Dw. Holt et A. Johnston, TACROLIMUS QUALITY ASSESSMENT, Therapeutic drug monitoring, 19(2), 1997, pp. 243-243